180 related articles for article (PubMed ID: 25965948)
1. Utilizing a high-throughput microfluidic platform to study hypoxia-driven mesenchymal-mode cell migration.
Zhang Y; Wen J; Zhou L; Qin L
Integr Biol (Camb); 2015 Jun; 7(6):672-80. PubMed ID: 25965948
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks.
Zhang Y; Zhang W; Qin L
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2344-8. PubMed ID: 24478127
[TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract][Full Text] [Related]
4. The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1.
Lin G; Gai R; Chen Z; Wang Y; Liao S; Dong R; Zhu H; Gu Y; He Q; Yang B
Eur J Pharmacol; 2014 Apr; 729():45-53. PubMed ID: 24561043
[TBL] [Abstract][Full Text] [Related]
5. A cell-ECM screening method to predict breast cancer metastasis.
Barney LE; Dandley EC; Jansen LE; Reich NG; Mercurio AM; Peyton SR
Integr Biol (Camb); 2015 Feb; 7(2):198-212. PubMed ID: 25537447
[TBL] [Abstract][Full Text] [Related]
6. Interaction study of cancer cells and fibroblasts on a spatially confined oxygen gradient microfluidic chip to investigate the tumor microenvironment.
Sun W; Chen Y; Wang Y; Luo P; Zhang M; Zhang H; Hu P
Analyst; 2018 Nov; 143(22):5431-5437. PubMed ID: 30311621
[TBL] [Abstract][Full Text] [Related]
7. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
8. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic pathobiology of breast cancer metastasis.
Schito L; Rey S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):239-245. PubMed ID: 28526262
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-mediated metastasis.
Chang J; Erler J
Adv Exp Med Biol; 2014; 772():55-81. PubMed ID: 24272354
[TBL] [Abstract][Full Text] [Related]
11. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
[TBL] [Abstract][Full Text] [Related]
12. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia enhances motility and EMT through the Na
Takatani-Nakase T; Matsui C; Hosotani M; Omura M; Takahashi K; Nakase I
Exp Cell Res; 2022 Mar; 412(1):113006. PubMed ID: 34979106
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
16. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo.
Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN
Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666
[TBL] [Abstract][Full Text] [Related]
17. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma.
Jiao M; Nan KJ
Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131
[TBL] [Abstract][Full Text] [Related]
18. AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis.
Ren Y; Zhou X; Yang JJ; Liu X; Zhao XH; Wang QX; Han L; Song X; Zhu ZY; Tian WP; Zhang L; Mei M; Kang CS
Cancer Lett; 2015 Jul; 362(2):174-82. PubMed ID: 25827073
[TBL] [Abstract][Full Text] [Related]
19. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells.
Shao C; Zhang J; Fu J; Ling F
Biochem Biophys Res Commun; 2015 Nov; 467(4):1083-9. PubMed ID: 26393908
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1 and breast cancer metastasis.
Liu ZJ; Semenza GL; Zhang HF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
